Physician profile
Jason Matthew Sansone
NPI 1942400221
$261,658.86
in general payments reported to CMS, 2019-2025
15 companies · $5,687 in 2025
The $5,687 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $28K · 2021: $43K · 2022: $33K · 2023: $43K · 2024: $23K · 2025: $5,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Travel and Lodging: $15K · Food and Beverage: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,000.00 |
| Travel and Lodging | $14,789.49 |
| Food and Beverage | $2,336.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $247,859.11 | 2019-2024 | Axsos, Gamma, Augment Injectable |
| Globus Medical, INC. | $5,545.24 | 2024-2025 | Tlif, Alif, Elsa |
| Wishbone Medical INC. | $3,000.00 | 2021 | |
| Medtronic, INC. | $1,610.68 | 2025 | Pivox Oblique Lateral Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology, Mazor X System |
| Arthrex, INC. | $1,379.68 | 2022 | |
| Exactech, INC. | $1,156.16 | 2021 | |
| Great Lakes Orthopedics | $728.85 | 2022 | |
| Smith+Nephew, INC. | $87.35 | 2025 | Real Intelligence |
| Depuy Synthes Sales INC. | $72.98 | 2023 | |
| Si-Bone, INC. | $70.20 | 2021 | |
| Enduromed, LLC | $42.32 | 2024 | |
| Medacta USA, INC. | $30.09 | 2024 | |
| Cerapedics INC. | $27.77 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $27.00 | 2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $21.43 | 2023 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Sansone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.